Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST-Reference-Cited by-同舟云学术

Plasma trough concentration of imatinib and its effect on therapeutic efficacy and adverse events in Japanese patients with GIST

Published:2023-03-27 Issue:5 Volume:28 Page:680-687
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Teranishi Ryugo,Takahashi Tsuyoshi^ORCID,Nishida Toshirou,Kurokawa Yukinori,Nakajima Kiyokazu,Koh Masahiro,Nishigaki Takahiko,Saito Takuro,Yamamoto Kazuyoshi,Yamashita Kotaro,Tanaka Koji,Makino Tomoki,Motoori Masaaki,Omori Takeshi,Hirota Seiichi,Hayashi Yoshito,Takehara Tetsuo,Eguchi Hidetoshi,Doki Yuichiro

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-023-02325-x.pdf

Reference38 articles.

1. DeMatteo RP, Lewis JJ, Leung D et al (2000) Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231:51–58

2. Hirota S, Isozaki K, Moriyama Y et al (1998) Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 279:577–580

3. Heinrich MC, Corless CL, Duensing A et al (2003) PDGFRA activating mutations in gastrointestinal stromal tumors. Science 299:708–710

4. Cho H, Nishida T, Takahashi T et al (2022) Impact of the KIT/PDGFRA genotype on prognosis in imatinib-naïve Japanese patients with gastrointestinal stromal tumor. Ann Gastroenterol 6:241–248

5. Demetri GD, Reichardt P, Kang YK et al (2013) Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet 381:295–302

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Contribution of genetic polymorphism in ABCB1 to individual variations of imatinib plasma levels in patients with gastrointestinal stromal tumor;Journal of Gastrointestinal Oncology;2024-04

2. The correlation of sarcopenia and adverse events of imatinib therapy postoperatively in gastrointestinal stromal tumor through computed tomography quantitative body composition;Journal of Gastrointestinal Surgery;2024-04

3. The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registry;Gastric Cancer;2023-12-25

4. 新規高速液体クロマトグラフィ分析装置を用いたイマチニブ血中濃度定量の精度評価;YAKUGAKU ZASSHI;2023-11-01